CRISPR/Cas9 for cancer therapy: hopes and challenges
M Martinez-Lage, P Puig-Serra, P Menendez… - Biomedicines, 2018 - mdpi.com
Cancer is the second leading cause of death globally and remains a major economic and
social burden. Although our understanding of cancer at the molecular level continues to …
social burden. Although our understanding of cancer at the molecular level continues to …
CRISPR–Cas-mediated chromosome engineering for crop improvement and synthetic biology
M Rönspies, A Dorn, P Schindele, H Puchta - Nature plants, 2021 - nature.com
Plant breeding relies on the presence of genetic variation, as well as on the ability to break
or stabilize genetic linkages between traits. The development of the genome-editing tool …
or stabilize genetic linkages between traits. The development of the genome-editing tool …
Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism
S García-Silva, A Benito-Martín, L Nogués… - Nature Cancer, 2021 - nature.com
Secreted extracellular vesicles (EVs) influence the tumor microenvironment and promote
distal metastasis. Here we analyzed the involvement of melanoma-secreted EVs in lymph …
distal metastasis. Here we analyzed the involvement of melanoma-secreted EVs in lymph …
Comprehensive analysis and accurate quantification of unintended large gene modifications induced by CRISPR-Cas9 gene editing
Most genome editing analyses to date are based on quantifying small insertions and
deletions. Here, we show that CRISPR-Cas9 genome editing can induce large gene …
deletions. Here, we show that CRISPR-Cas9 genome editing can induce large gene …
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells
Fusion oncogenes (FOs) are common in many cancer types and are powerful drivers of
tumor development. Because their expression is exclusive to cancer cells and their …
tumor development. Because their expression is exclusive to cancer cells and their …
TERRA recruitment of polycomb to telomeres is essential for histone trymethylation marks at telomeric heterochromatin
JJ Montero, I López-Silanes, D Megías… - Nature …, 2018 - nature.com
TERRAs are long non-coding RNAs generated from the telomeres. Lack of TERRA knockout
models has hampered understanding TERRAs' functions. We recently identified …
models has hampered understanding TERRAs' functions. We recently identified …
Unraveling Ewing sarcoma tumorigenesis originating from patient-derived mesenchymal stem cells
A Sole, S Grossetête, M Heintzé, L Babin, S Zaïdi… - Cancer research, 2021 - AACR
Ewing sarcoma is characterized by pathognomonic translocations, most frequently fusing
EWSR1 with FLI1. An estimated 30% of Ewing sarcoma tumors also display genetic …
EWSR1 with FLI1. An estimated 30% of Ewing sarcoma tumors also display genetic …
Gain-of-function mutations in DNMT3A in patients with paraganglioma
L Remacha, M Currás-Freixes, R Torres-Ruiz… - Genetics in …, 2018 - nature.com
Purpose The high percentage of patients carrying germline mutations makes
pheochromocytomas/paragangliomas the most heritable of all tumors. However, there are …
pheochromocytomas/paragangliomas the most heritable of all tumors. However, there are …
Induction of chromosomal translocations with CRISPR-Cas9 and other nucleases: understanding the repair mechanisms that give rise to translocations
E Brunet, M Jasin - Chromosome translocation, 2018 - Springer
Chromosomal translocations are associated with several tumor types, including
hematopoietic malignancies, sarcomas, and solid tumors of epithelial origin, due to their …
hematopoietic malignancies, sarcomas, and solid tumors of epithelial origin, due to their …
Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components
I Maggio, HA Zittersteijn, Q Wang, J Liu, JM Janssen… - Gene therapy, 2020 - nature.com
Enhancing the intracellular delivery and performance of RNA-guided CRISPR-Cas9
nucleases (RGNs) remains in demand. Here, we show that nuclear translocation of …
nucleases (RGNs) remains in demand. Here, we show that nuclear translocation of …